Article
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.
Nature genetics - 1 Dec 2013
Balbás-Martínez Cristina, Sagrera Ana, Carrillo-de-Santa-Pau Enrique, Earl Julie, Márquez Mirari, Vazquez Miguel, Lapi Eleonora, Castro-Giner Francesc, Beltran Sergi, Bayés Mònica, Carrato Alfredo, Cigudosa Juan C, Domínguez Orlando, Gut Marta, Herranz Jesús, Juanpere Núria, Kogevinas Manolis, Langa Xavier, López-Knowles Elena, Lorente José A, Lloreta Josep, Pisano David G, Richart Laia, Rico Daniel, Salgado Rocío N, Tardón Adonina, Chanock Stephen, Heath Simon, Valencia Alfonso, Losada Ana, Gut Ivo, Malats Núria, Real Francisco X
Abstract excerpt
Urothelial bladder cancer (UBC) is heterogeneous at the clinical, pathological and genetic levels. Tumor invasiveness (T) and grade (G) are the main factors associated with outcome and determine patient management. A discovery exome sequencing screen (n = 17), followed by a prevalence screen (n = 60), identified new genes mutated in this tumor coding for proteins involved in chromatin modification (MLL2, ASXL2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
